|
MED17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.466200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.346500E-02 |
| Normal-vs-Stage2 |
9.082800E-01 |
| Normal-vs-Stage3 |
6.297200E-01 |
| Normal-vs-Stage4 |
9.398500E-02 |
| Stage1-vs-Stage2 |
2.159200E-01 |
| Stage1-vs-Stage3 |
1.947250E-01 |
| Stage1-vs-Stage4 |
1.818490E-03 |
| Stage2-vs-Stage3 |
8.060000E-01 |
| Stage2-vs-Stage4 |
1.721440E-01 |
| Stage3-vs-Stage4 |
5.888200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.437980E-01 |
| Normal-vs-AfricanAmerican |
4.960800E-01 |
| Normal-vs-Asian |
1.518960E-01 |
| Caucasian-vs-AfricanAmerican |
9.652600E-01 |
| Caucasian-vs-Asian |
6.627400E-01 |
| AfricanAmerican-vs-Asian |
8.149600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.340800E-01 |
| Normal-vs-Female |
8.275700E-02 |
| Male-vs-Female |
1.707990E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.586100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.062600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.179000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.245630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.109400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.458900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.302000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.568400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.277220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.113200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.027000E-01 |
| Classical-VS-Follicular |
4.44830000001506E-06 |
| Classical-VS-Other |
5.661200E-01 |
| Classical-VS-Normal |
1.429660E-02 |
| Tall-VS-Follicular |
5.428300E-02 |
| Tall-VS-Other |
9.592200E-01 |
| Tall-VS-Normal |
5.516800E-01 |
| Follicular-VS-Other |
4.129200E-01 |
| Follicular-VS-Normal |
9.944000E-02 |
| Other-VS-Normal |
8.589600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.054400E-01 |
| Normal-vs-N1 |
7.151000E-01 |
| N0-vs-N1 |
8.363400E-01 |
|
|
